How to Deal with the Inevitable: Generating Real-World Data and Using Real-World Evidence for HTA Purposes – From Theory to Action
- 14 June 2019
- journal article
- research article
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 35 (4), 346-350
- https://doi.org/10.1017/s0266462319000400
Abstract
ObjectivesReal-world evidence (RWE), derived from real-world data (RWD), is already used, to some extent, for health technology assessment (HTA) purposes. With the increased availability of RWD, there is potential for more widespread use but also challenges ensuring reliable RWE for HTA. Opportunities to overcome key challenges, identified at a scoping meeting, were discussed during the 2019 HTA international (HTAi) Global Policy Forum (GPF).MethodsReflection of discussions using Design Thinking (an interactive process aimed to solve complex problems) between seventy-three representatives from not-for-profit, for-profit organizations, and HTAi leadership. The discussions were informed by a background paper, and presentations from three invited keynote speakers and eleven GPF members.ResultsSeveral options were listed for addressing the identified key challenges: quality and acceptability, governance and accountability, transferability, and informing decision making. The GPF emphasized that the HTA community should first understand what questions could be answered with RWE. Additionally, more clarity on methods, standards, streamlining RWD collection, data sharing across jurisdictions, replication of RWD, and expert analysis were mentioned as important priorities.ConclusionsThe HTA community is currently standing at a cross-road as it is not yet fully equipped to address these key challenges. It is, therefore, time for action. The community should start aligning on what is the best source of evidence according to purpose and how the data should be collected to create reliable evidence. It should also initiate the development of actions and guidance to properly develop and manage RWD/RWE to inform decision making across the technology lifecycle.Keywords
This publication has 9 references indexed in Scilit:
- Effectiveness in the Absence of Efficacy: Cautionary Tales From Real-World EvidenceJournal of Clinical Oncology, 2019
- Cost-effectiveness analyses using real-world data: an overview of the literatureJournal of Medical Economics, 2019
- Real-world studies no substitute for RCTs in establishing efficacyThe Lancet, 2019
- EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-makingBMJ Open, 2018
- Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision MakingValue in Health, 2017
- CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?International Journal of Technology Assessment in Health Care, 2016
- IMPROVING THE EFFECTIVENESS AND EFFICIENCY OF EVIDENCE PRODUCTION FOR HEALTH TECHNOLOGY ASSESSMENTInternational Journal of Technology Assessment in Health Care, 2015
- ADAPTIVE APPROACHES TO LICENSING, HEALTH TECHNOLOGY ASSESSMENT, AND INTRODUCTION OF DRUGS AND DEVICESInternational Journal of Technology Assessment in Health Care, 2014
- Using Real-World Data for Coverage and Payment Decisions: The ISPOR Real-World Data Task Force ReportValue in Health, 2007